aceMachine Learning-Driven Noninvasive Prediction of Liver Fibrosis in Unclassified Liver Disease
Chronic liver diseases (CLDs) frequently progress silently to advanced fibrosis or cirrhosis, yet existing predictive models have largely been developed for patients with clearly defined etiologies. Here, we asked whether a noninvasive machine-learning model based on routine clinical variables and liver stiffness measurement (LSM) could accurately identify significant liver fibrosis in patients with CLD of uncertain etiology, and whether such a model would add value beyond conventional fibrosis scores for clinic…
A Categorical Boosting model integrating routine serological markers, age, and liver stiffness measurement predicted biopsy-confirmed significant fibrosis in patients with CLD of uncertain etiology with AUC 0.827, outperforming FIB-4, GPR, Forns Index and LSM alone.
Retrospective single-center design limited to 503 biopsied patients with uncertain etiology at one hospital, constraining generalizability to broader CLD populations and prospective use.
Evidence
- Peer-reviewedMedComm2026-10-04
How should this claim be treated?
Truvace Impact Record TRV-2026-1316, v1: “Machine Learning-Driven Noninvasive Prediction of Liver Fibrosis in Unclassified Liver Disease.” Truvace, 2026-10-09. /record/TRV-2026-1316 (accessed at citation time). sha256 79b4ef2ec59e40e5…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-1316 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.